8-Cyclopentyl-1,3-dimethylxanthine
From Wikipedia, the free encyclopedia
(Redirected from C12H16N4O2)
Chemical compoundTemplate:SHORTDESC:Chemical compound
Pharmaceutical compoundTemplate:SHORTDESC:Pharmaceutical compound
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| UNII | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C12H16N4O2 |
| Molar mass | 248.286 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
8-Cyclopentyl-1,3-dimethylxanthine (8-Cyclopentyltheophylline, 8-CPT, CPX) is a drug which acts as a potent and selective antagonist for the adenosine receptors, with some selectivity for the A1 receptor subtype, as well as a non-selective phosphodiesterase inhibitor. It has stimulant effects in animals with slightly higher potency than caffeine.[1][2]
See also
[edit | edit source]References
[edit | edit source]| PDE1 | |
|---|---|
| PDE2 | |
| PDE3 | |
| PDE4 |
|
| PDE5 | |
| PDE7 | |
| PDE9 | |
| PDE10 | |
| PDE11 | |
| Non-selective | |
| Unsorted | |
See also: Receptor/signaling modulators | |
| Adamantanes | |
|---|---|
| Adenosine antagonists | |
| Alkylamines | |
| Ampakines | |
| Arylcyclohexylamines | |
| Benzazepines | |
| Cathinones |
|
| Cholinergics |
|
| Convulsants | |
| Eugeroics | |
| Oxazolines | |
| Phenethylamines |
|
| Phenylmorpholines | |
| Piperazines | |
| Piperidines |
|
| Phenethylpyrrolidines | |
| Racetams | |
| Psychedelics | |
| Tropanes |
|
| Tryptamines | |
| Others |
|
| Error creating thumbnail: | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |